NEURAXIS Trademark

Trademark Overview


On Monday, April 11, 2022, a trademark application was filed for NEURAXIS with the United States Patent and Trademark Office. The USPTO has given the NEURAXIS trademark a serial number of 97356330. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, October 10, 2024. This trademark is owned by Neuraxis, Inc.. The NEURAXIS trademark is filed in the Medical Instrument Products category with the following description:

Nerve stimulator apparatus; nerve stimulator apparatus for FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea, functional nausea, abdominal migraine, Crohn's Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes in FGID co-morbidities, sleep disturbances, psychological disorders, including mood, anxiety, and satiety, pain control, headache control, control of phantom limb pain, stump pain, reflex sympathetic dystrophy (RSD), peripheral neuropathies and other types of sympathetically mediated pain
neuraxis

General Information


Serial Number97356330
Word MarkNEURAXIS
Filing DateMonday, April 11, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, October 10, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 14, 2023

Trademark Statements


Description of MarkThe mark consists of the stylized word "NeurAxis" centered between curved geometric shapes forming a partial oval.
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesNerve stimulator apparatus; nerve stimulator apparatus for FGID, irritable bowel, functional dyspepsia, functional abdominal pain, nausea, functional nausea, abdominal migraine, Crohn's Disease, visceral hypersensitivity, chronic inflammatory bowel disease, changes in FGID co-morbidities, sleep disturbances, psychological disorders, including mood, anxiety, and satiety, pain control, headache control, control of phantom limb pain, stump pain, reflex sympathetic dystrophy (RSD), peripheral neuropathies and other types of sympathetically mediated pain

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, April 15, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeuraxis, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCarmel, IN 46032

Party NameNeuraxis, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVersailles, IN 47042

Trademark Events


Event DateEvent Description
Thursday, April 14, 2022NEW APPLICATION ENTERED
Friday, April 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 16, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, January 9, 2023ASSIGNED TO EXAMINER
Monday, January 9, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 25, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 14, 2023PUBLISHED FOR OPPOSITION
Tuesday, February 14, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, October 9, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 9, 2023SOU EXTENSION 1 FILED
Monday, October 9, 2023SOU EXTENSION 1 GRANTED
Wednesday, October 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 10, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, April 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, April 10, 2024SOU TEAS EXTENSION RECEIVED
Thursday, April 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2024SOU TEAS EXTENSION RECEIVED
Thursday, October 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 10, 2024SOU EXTENSION 3 FILED
Thursday, October 10, 2024SOU EXTENSION 3 GRANTED
Wednesday, April 10, 2024SOU EXTENSION 2 FILED
Wednesday, April 10, 2024SOU EXTENSION 2 GRANTED